Evolent Health
EVH
178 hedge funds and large institutions have $1.75B invested in Evolent Health in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 19 closing their positions.
97% more call options, than puts
Call options by funds: $5.05M | Put options by funds: $2.57M
58% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 19
6% more funds holding
Funds holding: 168 → 178 (+10)
5% more capital invested
Capital invested by funds: $1.66B → $1.75B (+$89.5M)
7% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 57
0.3% more ownership
Funds ownership: 95.24% → 95.53% (+0.3%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.3M |
| 2 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
+$20.3M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.5M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$7.46M |
| 5 |
MGIM
M&G Investment Management
London,
United Kingdom
|
+$5.55M |
Top Sellers
EVH Hedge Fund Activity: Q2 2021 in Review
178 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2021, worth a combined $1.75B — up 5.4% from $1.66B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new EVH positions and 19 closed out — a net gain of 11 holders — while 61 added to existing stakes and 57 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $29.3M. The largest seller was Eagle Asset Management, cutting an estimated $17.6M.
- 178 institutional investors held Evolent Health (EVH) as of Q2 2021, up from 168 in Q1 2021.
- Funds reported $1.75B of Evolent Health stock for Q2 2021, up 5.4% quarter-over-quarter.
- 30 funds opened new Evolent Health positions in Q2 2021 and 19 closed out, a net change of +11 holders.
- The largest Evolent Health buyer in Q2 2021 was Fidelity Investments, an estimated $29.3M added.
- The largest Evolent Health seller in Q2 2021 was Eagle Asset Management, an estimated $17.6M sold.
Based on aggregated 13F filings for Q2 2021.